Cargando…
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass
BACKGROUD: Myeloid sarcoma (MS) is a rare neoplasm of immature myeloid precursors that form tumor mass outside the bone marrow. The diagnosis of de novo MS can be challenging, particularly in patients with no prior history of hematologic malignancies or when MS involves unusual anatomic sites. CASE...
Autores principales: | Bao, Haiyan, Gao, Juehua, Chen, Yi-Hua, Altman, Jessica K., Frankfurt, Olga, Wilson, Amanda L., Sukhanova, Madina, Chen, Qing, Lu, Xinyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440110/ https://www.ncbi.nlm.nih.gov/pubmed/30922345 http://dx.doi.org/10.1186/s13000-019-0804-6 |
Ejemplares similares
-
Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia—association with young age and myeloid sarcomas?
por: Panagopoulos, Ioannis, et al.
Publicado: (2016) -
Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
por: Gao, Juehua, et al.
Publicado: (2021) -
MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
por: Rabello, Doralina do Amaral, et al.
Publicado: (2018) -
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions
por: Meyer, Claus, et al.
Publicado: (2019) -
MLL-ELL fusion gene in an acute myelomonocytic leukemia patient transformed from acute promyelocytic leukemia
por: Hu, Wang Qiang, et al.
Publicado: (2015)